Unicorn Pacific Corporation   Report issue

For profit Phase 2
Founded: Port Vila Vanuatu (1982)
Status: No NME R&D (1982)

Organization Overview

First Clinical Trial
2008
NCT01096810
First Marketed Drug
2016
sodium bicarbonate
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

UNICORN

Active Ingredients

Marketed Drugs (2)

omeprazole (prilosec) (2016)

sodium bicarbonate (2016)

Drugs in Phase 2 Trials (1)

tbl12 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Multiple Myeloma (Phase 2)

Neoplasms, Plasma Cell (Phase 2)

Smoldering Multiple Myeloma (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 1